Nicolas Sitchon
Directeur Général chez S1 BioPharma, Inc.
Profil
Nicolas Gomez Sitchon is currently the Chairman, President & Chief Executive Officer at S1 BioPharma, Inc. He has been in this position since 2010.
He has a graduate degree from Boston University School of Medicine and an MBA from Questrom School of Business.
Postes actifs de Nicolas Sitchon
| Sociétés | Poste | Début |
|---|---|---|
S1 BioPharma, Inc.
 S1 BioPharma, Inc. Pharmaceuticals: MajorHealth Technology S1 BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of drugs for the treatment of sexual dysfunction in both women and men. Its product portfolio include Lorexy's, Orexa, S1B-307, and S1B-3006. The company was founded in 2008 and is headquartered in New York, NY. | Directeur Général | 01/10/2010 |
Formation de Nicolas Sitchon
| Questrom School of Business | Masters Business Admin |
| Boston University School of Medicine | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
S1 BioPharma, Inc.
S1 BioPharma, Inc. Pharmaceuticals: MajorHealth Technology S1 BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of drugs for the treatment of sexual dysfunction in both women and men. Its product portfolio include Lorexy's, Orexa, S1B-307, and S1B-3006. The company was founded in 2008 and is headquartered in New York, NY. | Health Technology |
